Is there a role for immune checkpoint inhibitors in selected rare subtypes of soft tissue sarcoma?

Immunotherapy. 2021 Feb;13(2):91-93. doi: 10.2217/imt-2020-0301. Epub 2020 Dec 9.
No abstract available

Keywords: cancer; checkpoint inhibitors; immunotherapy; pembrolizumab; rare; sarcoma.

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Immunotherapy
  • Rare Diseases
  • Sarcoma / classification
  • Sarcoma / drug therapy*
  • Soft Tissue Neoplasms / classification
  • Soft Tissue Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Immune Checkpoint Inhibitors
  • pembrolizumab